The Wilky Lab studies the interaction between sarcomas, cancers of bones and soft tissues with the immune system. We study how sarcomas can avoid detection and kill by T cells and try to overcome this resistance using combinations of immune-boosting therapies with chemotherapies. New combination therapies are explored by analyzing patient samples of tissue and blood after treatment on cutting edge clinical trials but are also modeled in mice models of sarcoma.